Dr. Robin Franklin

Scientific Adviser

Dr. Robin Franklin’s group at the University of Cambridge have been working on the idea that the brain contains a population of endogenous stem cells or progenitors that can be recruited to become myelinating cells in MS, and possibly other myelin disorders.  They have identified some key molecules that might be used in future clinical trials, to promote ‘host’ repair.